Skip to content

Drug interactions

Dabigatran etexilate + Paliperidone

Severity: Minor

Dabigatran etexilate and Paliperidone: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Paliperidone is a weak P-glycoprotein substrate and inhibitor, and a clinically meaningful rise in dabigatran exposure is not established. Any effect is likely small.

What this interaction means in plain words

Dabigatran etexilate and Paliperidone have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Dabigatran etexilate belongs to Cardiovascular; Paliperidone belongs to Central Nervous System.

Evidence level: Low

Why it happens

Possible weak P-glycoprotein inhibition.

What to do

No routine adjustment needed; monitor for bleeding in patients with renal impairment.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Dabigatran etexilate and Paliperidone, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Dabigatran etexilate with Paliperidone?

MediHelp rates the interaction as minor. Dabigatran etexilate and Paliperidone have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Paliperidone is a weak P-glycoprotein substrate and inhibitor, and a clinically meaningful rise in dabigatran exposure is not established. Any effect is likely small.

How serious is the interaction between Dabigatran etexilate and Paliperidone?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No routine adjustment needed; monitor for bleeding in patients with renal impairment.

What other medicines interact with Dabigatran etexilate?

MediHelp also lists interactions of Dabigatran etexilate with, for example, Defibrotide, Ketorolac, Mifepristone. The full list is on the Dabigatran etexilate page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in